[Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
Stiegler
H
H
Forschergruppe Diabetes, Krankenhaus München-Schwabing.
Diehm
C
C
Grom
E
E
Martin
M
M
Mörl
H
H
Rudofsky
G
G
Vogelberg
K H
KH
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000527:Alprostadil / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D016523:Foot Ulcer / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged
D000527:Alprostadil
Placebokontrollierte, doppelblinde Studie zur Wirksamkeit von i.v. Prostaglandin E1 bei Diabetikern mit AVK im Stadium IV.